In our study, there was no immunoreactivity for TGF-β in MCDKs associated with obstruction, while on the other hand, we found all cases of syndromic MCDK without evidence of obstruction to be immunoreactive for TGF-β (see Tables 1 and 2 for clinical information). This evidence concerns the gene TGFB1 and multicystic dysplastic kidney.